Suppr超能文献

腹主动脉瘤破裂的血管内修复对胃肠和肾功能的影响。

The impact of endovascular repair of ruptured abdominal aortic aneurysm on the gastrointestinal and renal function.

作者信息

Makar R R, Badger S A, O'Donnell M E, Soong C V, Lau L L, Young I S, Hannon R J, Lee B

机构信息

Vascular and Endovascular Surgery Unit, Belfast City Hospital, Lisburn Road, Belfast BT9 7AB, UK.

出版信息

Int J Vasc Med. 2014;2014:178323. doi: 10.1155/2014/178323. Epub 2014 Jan 29.

Abstract

Introduction. Systemic effects of ruptured abdominal aortic aneurysm (rAAA) may be altered by the mode of surgery. This study aimed to determine systemic effects of endovascular aneurysm repair (EVAR) compared to open repair (OR). Patients and Methods. Consecutive patients with rAAA were repaired by OR or EVAR according to computerised tomographic (CT) findings. Renal function was monitored by estimated glomerular filtration rate (eGFR), serum urea and creatinine, and urinary albumin creatinine ratio (ACR). Hepatic function was assessed postoperatively for 5 days. Intestinal function was determined by the paracetamol absorption test. Intestinal permeability was assessed by urinary lactulose/mannitol ratio. Results. 30 rAAA patients were included. Fourteen had eEVAR and sixteen eOR. Serum urea were higher in eOR, while creatinine was similar between groups. Hepatic function showed no intergroup difference. Paracetamol absorption was increased in eEVAR group at day 3 compared to day 1 (P = 0.03), with no similar result in eOR (P = 0.24). Peak lactulose/mannitol ratio was higher in eOR (P = 0.03), with higher urinary L/M ratio in eOR at day 3 (P = 0.02). Clinical intestinal function returned quicker in eEVAR (P = 0.02). Conclusion. EVAR attenuated the organ dysfunction compared to open repair. However, a larger comparative trial would be required to validate this. The clinical trial is registered with reference number EUDRACT: 2013-003373-12.

摘要

引言。腹主动脉瘤破裂(rAAA)的全身效应可能因手术方式而改变。本研究旨在确定与开放修复(OR)相比,血管内动脉瘤修复(EVAR)的全身效应。患者与方法。根据计算机断层扫描(CT)结果,对连续性rAAA患者采用OR或EVAR进行修复。通过估计肾小球滤过率(eGFR)、血清尿素和肌酐以及尿白蛋白肌酐比值(ACR)监测肾功能。术后5天评估肝功能。通过对乙酰氨基酚吸收试验确定肠道功能。通过尿乳果糖/甘露醇比值评估肠道通透性。结果。纳入30例rAAA患者。14例行EVAR,16例行OR。OR组血清尿素较高,而两组间肌酐相似。肝功能无组间差异。与第1天相比,EVAR组在第3天对乙酰氨基酚吸收增加(P = 0.03),OR组无类似结果(P = 0.24)。OR组峰值乳果糖/甘露醇比值较高(P = 0.03),OR组在第3天尿L/M比值较高(P = 0.02)。EVAR组临床肠道功能恢复更快(P = 0.02)。结论。与开放修复相比,EVAR减轻了器官功能障碍。然而,需要更大规模的对比试验来验证这一点。该临床试验已注册,注册号为EUDRACT:2013 - 003373 - 12。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb06/3927867/d0bc1d4c3bbd/IJVM2014-178323.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验